Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

This study has been completed.
Sponsor:
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT00111449
First received: May 20, 2005
Last updated: May 13, 2013
Last verified: May 2013